Spain: Pharmaco-economic analyses and their implications

Published on April 5, 2023

Pharmaco-economic analyses are gaining momentum in Spain, but what are the potential implications? In the recent revisions issued by the Spanish health authorities, the inclusion of an economic analysis in the Therapeutic Positioning Reports (IPTs) is required leading to a more comprehensive evaluation of the therapy prior to price and reimbursement (P&R) negotiations. Our experts Ana Mozetic, Patricia Laviña, Carlos Ardévol, and Marta Fernández have analyzed how these evaluations are being carried out during this initial phase to identify current trends and anticipate potential implications for manufacturers.

In Spain, as part of the P&R process and negotiations, pharmaceuticals are evaluated by creating an IPT, which is used to understand the product’s value and positioning. The IPT Consolidation Plan, published in December 2020, updates IPT development starting in January 2021 by establishing a new…

spain

Continue reading on website
Other news

Fluctuating gas prices in the US: a chance for EVs?

April 4, 2023
With nearly 40 percent of US respondents saying they would still not consider an electric vehicle even if gas prices were as high as six dollars per gallon – what are the implications for the automotive industry?Gas prices were on a roller coaster last year in the US. After hitting record highs in March 2022, gas prices surged even higher.The US national average eventually reached five US dollars

UK: Integrated Care Systems – lessons and outlook from the first six months

April 5, 2023
In July 2022, Integrated Care Systems (ICSs) became the statutory bodies responsible for commissioning medicines and budget allocation, replacing Clinical Commissioning Groups (CCGs). In this article, we review the key budget- and funding-related challenges, the outlook for 2023, and implications for therapies preparing to launch in the UK.UK financial environmentThe current UK healthcare environm